Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • TSLP‐targeting therapy: Beyond...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
TSLP‐targeting therapy: Beyond allergy?

TSLP‐targeting therapy: Beyond allergy?

Bibliographic Details
Main Authors: Risa Ebina‐Shibuya, Warren J. Leonard
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Clinical and Translational Medicine
Subjects:
tezepelumab
thymic stromal lymphopoietin
Online Access:https://doi.org/10.1002/ctm2.1241
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1002/ctm2.1241

Similar Items

  • Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
    by: Andrew Menzies-Gow, et al.
    Published: (2020-10-01)
  • NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    by: Andrew Menzies-Gow, et al.
    Published: (2020-10-01)
  • Role of the TSLP and its Receptor in the Treatment of Asthma
    by: Miguel Estravís, et al.
    Published: (2023-04-01)
  • Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
    by: Corren J, et al.
    Published: (2021-01-01)
  • Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study
    by: Emson C, et al.
    Published: (2021-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs